Broncus has entered an equity transfer agreement to acquire a 100% equity interest in Chinese device company Hangzhou Jingliang.

Asep Medical Holdings Inc. ("Asep" or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that, through its subsidiary Sepset Biosciences Inc. ("Sepset"), it has signed a definitive joint venture agreement (the "JV Agreement") with leading Chinese medical diagnostic company, Sansure Biotech Inc. ("Sansure"), through its subsidiary, Hunan Xiang Jiang Sansure Biotech Fund, L.P. (the "Sansure Fund"). Sansure Fund is an investment fund formed by Sansure, Changsha Sanway Spring Venture Capital CO., Ltd. ("Sanway Spring") and certain other investors. The JV Agreement was signed on October 27, 2023.

As of 31 October 2023, over 50 Chinese IVD listed companies have announced their Q3 financial results.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

On 27 October, Ministry of Finance of the People’s Republic of China and National Health Commission of the People’s Republic of China issued a notice.

China Association of In Vitro Diagnostics (CAIVD) and In Vitro Diagnostics Society of China Association for Medical Devices Industry jointly compiled this report.

Listed companies with main IVD business in China have completed the disclosure of their financial results in the first half of 2023.

Foundation Medicine announced on Monday that it is expanding its partnership with Sequanta Technologies to provide its genomic profiling tests for research and oncology therapy development in China.

By the end of 2022, the total number of medical and health institutions nationwide reached 1,032,918, an increase of 1,983 compared to the previous year.

China Association of In Vitro Diagnostics (CAIVD) and In Vitro Diagnostics Society of China Association for Medical Devices Industry jointly compiled this report.